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Abstract
Background: Documentation of the hospitalizations rates following a stroke provides the inputs
required for planning health services and to evaluate the economic efficiency of any new therapies.
Methods: Hospitalization rates by cause were examined using administrative data on 18,695
patients diagnosed with ischemic stroke (first or subsequent, excluding transient ischemic attack)
in Saskatchewan, Canada between 1990 and 1995. Medical history was available retrospectively to
January 1980 and follow-up was complete to March 2000. Analyses evaluated the rate and timing
of all-cause and cardiovascular hospitalizations within discrete periods in the five years following
the index stroke. Cardiovascular hospitalizations included patients with a primary diagnosis of
ischemic stroke, transient ischemic attack, myocardial infarction, stable or unstable angina, heart
failure or peripheral arterial disease.
Results: One-third (36%) of patients were identified by a hospitalized stroke. Mean age was 70.5
years, 48.0% were male, half had a history of stroke or a transient ischemic attack at the time of
their index stroke. Three-quarters of the patients (72.7%) were hospitalized at least once during a
mean follow-up of 4.6 years, accruing CAD $24 million in the first year alone. Of all hospitalizations,
20.4% were related to cardiovascular disease and 1.6% to bleeds. In the month following index
stroke, 12.5% were admitted, an average of 1.04 times per patient hospitalized. Strokes accounted
for 33% of all hospitalizations in the first month. The rate diminished steadily throughout the year
and stabilized in the second year when approximately one-third of patients required hospitalization,
at a rate of about one hospitalization for every two patient-years. Mean lengths of stay ranged from
nine days to nearly 40 days. Close-fitting Weibull functions allow highly specific probability
estimates. Other cardiovascular risk factors significantly increased hospitalization rates.
Conclusion: After stroke, there are frequent hospitalizations accounting for substantial additional
costs. Though these rates drop after one year, they remain high over time. The number of other
cardiovascular causes of hospitalization confirms that stroke is a manifestation of disseminated
atherothrombotic disease.
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Background
There has been increasing recognition that health policy
founded on methodologically sound analyses is of vital
concern for clinicians [1]. As better methods of preven-
tion, diagnosis, treatment and rehabilitation become
available, it is important to carry out these evaluations
that go beyond the clinical trials to provide estimates of
the relative returns of the new interventions and help pol-
icy makers discriminate what is useful and affordable [2].
Outdated or incomplete information is a major problem
for those trying to inform the authorities who make deci-
sions regarding the use of limited health care resources.
Assembling these inputs is not an easy task and failure to
do so can lead to serious inaccuracies in the modeled out-
comes, and thus, in the messages communicated [3].
Therefore, it is important to examine and report on the
use of resources, particularly those playing a major role in
the management of these patients. These reports must be
detailed enough to enable analysts to adjust the measures
to their own context and, in the context of any chronic ill-
ness, time-dependency is one of the crucial details.
For stroke, these evaluations involve modeling the
patients' course over time and accounting for all of the
consequences and their costs. While the initial manage-
ment of stroke is reasonably well documented [4,5], the
ensuing resource use is much less so [6]. A key component
of this is the expense for admissions to hospital following
a stroke. Ideally, the long-term hospitalization rates are
obtained from long-term follow-up studies, but although
several have been reported [7-9], none of them provide
the information in a form that can be used by other
researchers to evaluate new interventions in other locales.
Rather than estimates of the costs per se (which vary from
place to place and with time), what is required are the
resource use rates. Hospitalization rates have been pub-
lished for the Medicare population in the United States
(US) [10], but these are cross-sectional, not given as func-
tions of time since stroke and other determinants.
Thus, the objective of this work was to provide updated,
comprehensive information on the rates of hospitaliza-
tion following an ischemic stroke. In this paper, we
present a detailed analysis of hospitalizations over the
first five years. While this does not address the economic
efficiency of any one intervention, it is the information
required for such analyses. We provide the information in
a manner that enables other analysts to incorporate it in
economic models of the implications of new treatments.
Methods
Data were obtained from Saskatchewan Health, a provin-
cial government department that oversees ten health care
databases [11], including outpatient prescriptions and
physician services, hospitalizations, and vital statistics for
approximately one million residents covered by health
insurance (excluding indigenous people [12]). All adults
(21 years or older) diagnosed with an ischemic stroke
between January 1, 1990 and December31, 1995 were
sought. To achieve a comprehensive enumeration of these
patients, it was decided to take records from both the hos-
pital services file and the physician services file because
the first notice of a stroke may appear in either file as the
physician in the emergency room may be the first one to
record the diagnosis; and also some patients with stroke
may not be hospitalized. This analysis was part of a larger
study of patients with atherothrombosis [13]. The first of
ischemic stroke (ICD-9 codes 433, 434, 436, and 362.3),
myocardial infarction, or peripheral arterial disease docu-
mented during the study period was the index diagnosis
and its first recording in either file was the index date. His-
tory was available to January 1, 1980 and follow-up
through March 2000.
Medical history prior to the index diagnosis was examined
using data from the hospital services file and the physician
services file complemented by the prescription file to
identify risk factors. Risk factors of interest were based pri-
marily on ICD-9 codes recorded in the hospital and phy-
sician services files: atrial fibrillation, angina, diabetes
mellitus, heart failure, treatment of hypercholesterolemia
(based on documentation of a prescription), hyperten-
sion, prior ischemic stroke, myocardial infarction, and
transient ischemic attack. Data on smoking history or lab-
oratory values were not available in these data bases.
The risk and timing of first subsequent hospitalization fol-
lowing the index stroke was estimated using standard fail-
ure time techniques [14]. A subsequent hospitalization
was considered if it began at least seven days beyond the
index date to avoid counting the initial hospitalization
following a physician-recorded diagnosis, and to avoid
inter-hospital transfers for the first acute hospitalization.
The hospitalizations were classified as due to cardiovascu-
lar disease if the primary diagnosis was ischemic stroke,
transient ischemic attack, myocardial infarction, stable or
unstable angina, heart failure or peripheral arterial dis-
ease. Given that many of these patients receive anticoagu-
lants or aspirin, hospitalizations due to bleeds
(intracranial hemorrhage, gastrointestinal hemorrhage or
unspecified hemorrhage) were also examined separately.
As many patients are hospitalized more than once, all
hospitalizations were considered using three additional
measures (i.e., frequency, hazard, total rate) in each
period – days 1–30, 31–60, 61–180, 181–365 – and
annually thereafter. Frequency is expressed as hospitaliza-
tions per patient hospitalized (per month), hazard is
expressed as patients hospitalized per patient year, and
the total rate is expressed as hospitalizations per patient
year.BMC Health Services Research 2006, 6:99 http://www.biomedcentral.com/1472-6963/6/99
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Parametric Weibull regression analyses [14,15], were used
to fit these rates as functions of time. A two-parameter
Weibull was chosen because it is a very flexible distribu-
tion that fit the decreasing rates over time very well. The
shape parameter indicates the slope of the curve while the
scale parameter provides a starting point. Using multivar-
iate Cox proportional hazards [16,17] the effect of poten-
tial risk factors (age over 65 years, sex, hypertension,
diabetes, hypercholesterolemia, atrial fibrillation, heart
failure, angina, prior transient ischemic attack, ischemic
stroke, or myocardial infarction) was examined, using the
same units of analysis as for the crude estimates. Rates of
hospitalization were estimated from the index date to the
date of death, patient censoring or the last follow-up date
available.
The costs of a hospitalization were obtained from the
Ontario Case Cost Project Case Mix Group [18,19] in
2002 Canadian dollars (CAD $1 = USD $0.65 = €0.70 on
June 1, 2002). As costs do not translate well among coun-
tries, a more applicable "relative value weight" was cre-
ated by dividing the hospitalization cost by the per diem
for myocardial infarction (CAD $566.59, USD$368.28,
€396.61). No discounting was applied, as there is no
comparative analysis with differential timing.
Results
Of 18,704 patients (Table 1) with index stroke (nine
excluded for administrative reasons), 60.2% died and
3.1% emigrated during follow-up. Patients were predom-
inantly elderly and most had one or more risk factors.
There were 53,406 hospitalizations over 86,153 person-
years of followup (mean 4.6 years), a hospitalization haz-
ard of 62.0/100 person-years. Most patients (72.7%) were
hospitalized at least once, with mean time to first hospi-
talization 1.59 years (sd 1.97, median 0.74); mean length
of stay 13.9 days (median 5, range 1 to >180, standard
deviation 51.7).
At the time of index stroke, 21.3% of patients had previ-
ously filled at least one prescription for an ACE inhibitor,
30.6% for a beta blocker, 23.4% a calcium channel
blocker, 4.4% a lipid lowering agent (e.g., statin), 37.3%
aspirin, and less than 1% each for dipyridamole or ticlo-
pidine. Following the index stroke, 32.9% of patients
filled at least one prescription for an ACE inhibitor, 16.9%
beta blocker, 26.1% calcium channel blocker, 8.4% lipid
lowering agent, 36.0% aspirin, 4.5% ticlopidine, 1.1%
clopidogrel, and less than 1% dipyridamole.
Stroke and transient ischemic attack accounted for 10.7%
of subsequent hospitalizations, other cardiovascular dis-
ease for 9.7%, and hemorrhage for 1.6%. The majority of
hospitalizations (78%) were for unrelated diagnoses,
though in the first six months, cardiovascular disease was
common (43.0%). Most admissions were from emer-
gency (38.9%) or classified "urgent" (31.5%), especially
for hemorrhage (80.4%). Stays ranged from a low of 8.8
(± 25.3) days if discharged home to a high of 43.5 (±
138.0) among patients who died; Hospitalizations for
ischemic stroke (39.6 ± 117.0 days) or intracranial hem-
orrhage (35.8 ± 88.9 days) were longest while other cardi-
ovascular disease (11.8 ± 32.6 days) and other bleeds
(10.5+29.5 days) were much lower; transient ischemic
attacks were the shortest at 9.0 (± 36.3) days.
In the month following index stroke, 12.5% were admit-
ted, an average of 1.04 times per patient hospitalized
(Table 2). The rate diminished steadily throughout the
year and stabilized in the second year when approxi-
mately one-third of patients required hospitalization, at a
rate of about one hospitalization for every two patient-
years. The resulting equation for the total rate (TR) of hos-
pitalizations over time follows a Weibull distribution (r2
= 0.95):
TR = 2.82t-0.2394
This equation can be used to derive the probability of hos-
pitalization at any point in time. For example, beginning
at day 366 following stroke, the expected total rate is 0.69
Table 1: Patient characteristics, medical history, and principal 
diagnosis
Item Result
Age (mean ± standard deviation, years) 70.5 ± 9.9
Male 8,980 (48)*
Qualifying diagnosis in hospital 6,807 (36)
Medical History
Atrial Fibrillation 1,812 (10)
Angina 4,848 (26)
Heart Failure 5,319 (28)
Diabetes Mellitus 4,485 (24)
Hypercholesterolemia 1,183 (6)
Hypertension 12,597 (67)
Ischemic Stroke 4,405 (24)
Myocardial Infarction 2,209 (12)
Transient Ischemic Attack 5,150 (28)
Identifying ICD-9 code
436 (acute, but ill-defined cerebrovascular disease) 83.2%
434.9 (occlusion of cerebral arteries, unspecified) 8.4%
434 (occlusion of cerebral arteries) 3.2%
433.1 (occlusion and stenosis of precerebral arteries, 
carotid artery)
1.8%
434.1 (occlusion of cerebral arteries, cerebral 
embolism)
1.5%
Other (362.3. 433.2–9)† 1.9%
* number (%)
†Retinal vascular occlusion, Occlusion and stenosis of precerebral 
arteries, vertebral artery, multiple and bilateral, other specified 
precerebral artery, unspecified precerebral artery (NOS)BMC Health Services Research 2006, 6:99 http://www.biomedcentral.com/1472-6963/6/99
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per year; so in the following month the probability of
being hospitalized is about 0.057. After three years, this
drops to 0.044 (inthefirst month of the fourth year).
The rate for cardiovascular disease (Table 3) followed the
same Weibull pattern with A = 1.88, B = -0.4263 (r2 =
0.96). Subsequent strokes accounted for 33.0% of hospi-
talizations in the first month, transient ischemic attacks
for 5.8% (Table 4), with Weibull functions: A = 2.86, B =
-0.6552 (r2 = 0.98) for stroke; A = 0.274, B = -0.4539 (r2 =
0.96) for transient ischemic attack. Rates of hospitaliza-
tions related to non-cerebrovascular disease (i.e., myocar-
dial infarction, angina) were considerably lower at all
points in time (range: 0.01–0.02 per patient year).
Predictors
The risk of hospitalization was increased by 36.2% (95%
CI: 30.3%–42.4%) if older than 65 years; by 18.1%
(14.1%–22.2%) in men; by 20.5% (15.8%–25.3%) in
diabetics; by 20.9% (13.9%–28.4%) with atrial fibrilla-
tion; by 21.6% (16.6%–26.8%) with heart failure; by
12.1% (7.6%–16.8%) with angina; by 10.1% (2.7%–
14.8%) with prior myocardial infarction; by 14.0%
(9.7%–18.4%) among hypertensives; by 4.0% (0.2%–
8.1%) with previous transient ischemic attack. History of
stroke decreased the risk of hospitalization by 8.0%
(4.2%–11.7%). Hypercholesterolemia was not a signifi-
cant predictor.
These effects were more pronounced if only cardiovascu-
lar disease hospitalizations were considered: 67.2%
(55.0%–80.5%) increase if older than 65 years; 34.3%
(27.3%–41.7%) in men; 40.8% (32.8%–49.2%) in dia-
betics; 38.4% (27.4%–50.3%) with atrial fibrillation;
35.9% (27.9%–44.5%) with heart failure; 23.1%
(15.9%–30.8%) with angina; 24.1% (14.8%–34.0%)
with prior myocardial infarction; and 36.1% (27.7%–
45.0%) among hypertensives. Neither prior stroke nor
transient ischemic attack was significantly associated with
risk of cardiovascular disease hospitalization, however.
The impact of hypercholesterolemia remained
unchanged.
Costs
In the year following index stroke, the 18,695 patients
accumulated CAD $24 million (USD $15.6, €16.8 in
2002) in hospitalizations due to cardiovascular disease.
This is equivalent to a relative value weight of 2.3 per
diems per patient, though many patients add little cost
because they die (23% by one year). These hospitaliza-
tions are only a fraction of the total resource consump-
tion. In subsequent years, the cost due to these
hospitalizations dropped to a relative value of 0.95 per-
diem/patient/year; also influenced by the ongoing high
mortality (50% by year five). The occurrence of bleeds
requiring hospitalization is much lower but still adds
CAD $5 million (USD $3.25, €3.5 in 2002) in year one;
remaining fairly steady at a relative value of 0.17 per
diems/patient/year.
The pattern of costs varies somewhat from year to year
(Figure 1). They are not only highest in the first year after
diagnosis, but they are also largely due to stroke or tran-
sient ischemic attack. In subsequent years the amounts
due to other cardiovascular disease and bleeds remain in
absolute terms about the same, but grow in importance
because stroke/transient ischemic attack drops considera-
bly.
Table 2: All cause hospitalizations among patients diagnosed with ischemic stroke according to time since index stroke
At Risk All Cause Hospitalization
Time Period N* PY** Patients Hosp† %‡ Freq§ Hazard# Total Rate°
Month 1 18,695 1,429 2,338 2,440 12.5 1.04 1.64 1.71
Month 2 16,821 1,359 1,375 1,455 8.2 1.06 1.01 1.07
Months 3–6 16,319 5,274 3,325 4,386 20.4 0.44 0.63 0.83
Months 7–12 15,361 7,457 3,436 4,870 22.4 0.23 0.46 0.65
Year 2 14,436 13,642 4,654 7,935 32.2 0.14 0.34 0.58
Year 3 12,917 12,265 3,992 6,903 30.9 0.14 0.33 0.56
Year 4 11,628 11,081 3,611 5,948 31.1 0.14 0.33 0.54
Year 5 10,514 9,997 3,269 5,351 31.1 0.14 0.33 0.54
*N=number surviving to beginning of each time period
**PY=person years accumulated by patients during each period
†Hospitalization count in each period
‡% gives the proportion of patients hospitalized
§Frequency expressed as hospitalizations per patient hospitalized (per month)
#Hazard expressed as patients hospitalized per patient year
°Total rate expressed as hospitalizations per patient yearBMC Health Services Research 2006, 6:99 http://www.biomedcentral.com/1472-6963/6/99
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Discussion
In this study, we analyzed a large administrative database
to estimate the hospitalization rates following an
ischemic stroke, their time course, and the ensuing costs.
This information can be used to carry out budget impact
and other economic analyses required by policy makers to
address the appropriateness and affordability of novel
interventions [2,3]. While costs of stroke have been docu-
mented often [20] and some studies of the post-stroke
course have recently been published [21,22], to our
knowledge ours is the first to provide a detailed descrip-
tion of hospitalizations following an ischemic stroke in an
unrestricted (i.e., no exclusion criteria) population with
long-term follow-up. This study was comparable to other
published studies in terms of the proportion of patients
suffering a secondary event (72.7% vs 76.7%) [21] and
medication use post index event [22].
We have provided functions to estimate the rate at any
time after a stroke, by cause of hospitalization, so they can
be used in economic models [23,24]. Transition probabil-
ities in Markov models or recurrence frequencies in more
sophisticated discrete event simulations can be easily cal-
culated from the hazards. For settings where it is felt that
the rates based on Saskatchewan data may not apply
directly, the estimates can be recalibrated by using the
periodto-period ratios and applying these to a known rate
for a specific period in the setting at issue.
Hospitalization, particularly for cardiovascular problems,
is most frequent in the first six months following the
stroke, highlighting the importance of action plans to pre-
vent these complications in stroke survivors. From year
two onward, less than half of the hospitalizations are due
to cardiovascular disease and even fewer because of subse-
quent strokes or transient ischemic attacks. The likelihood
of hospitalization (both all-cause or for cardiovascular
disease) is highest among patients over 65 years of age.
Atrial fibrillation at the time of the stroke is also a key fac-
tor in determining these hospitalizations. Presence of
heart failure greatly increases the risk of all-cause hospital-
ization, whereas, diabetes plays a major role in predicting
hospitalization due to cardiovascular disease. Other
important risk factors included male gender, prior myo-
cardial infarction, and hypertension. Prior stroke was pro-
tective of all-cause hospitalization in this analysis.
Although perhaps counterintuitive, this is likely a marker
of a select, healthier population who survived an earlier
event long enough to suffer a subsequent stroke and qual-
ify for this analysis.
The rates estimated here consider the hospitalizations
without attribution to the stroke per se. Thus analysts
must be cautious about imputing all hospitalizations to
the preceding stroke – many would likely occur regardless
given the age of these patients and other conditions they
have. Whether stroke aggravates the severity of those other
conditions or in some way leads to increased rates of unre-
lated hospitalizations cannot be determined from this
study. Nevertheless, comparison with other conditions
suggests that stroke does lead to an increase in hospitali-
zations. For example, in the same Saskatchewan popula-
tion [25], the rate of hospitalization for cardiovascular
disease in the month following a diagnosis of peripheral
arterial disease was half that documented here. After a
myocardial infarction, the initial rates were higher. Never-
theless, in both these other conditions, the rates in years
two and beyond are very similar to that after stroke, sug-
Table 3: Cardiovascular disease-related hospitalizations among patients diagnosed with ischemic stroke according to time since index 
stroke
At Risk Hospitalization Due to Cardiovascular Disease
Time Period N* PY** Patients Hosp† %‡ Freq§ Hazard# Total Rate°
Month 1 18,695 1,429 1,026 1,049 5.5 1.02 0.72 0.73
Month 2 16,821 1,359 447 451 2.7 1.01 0.33 0.33
Months 3–6 16,319 5,274 1,061 1,208 7.4 0.28 0.20 0.23
Months 7–12 15,361 7,457 871 1,024 5.7 0.20 0.12 0.14
Year 2 14,436 13,642 1,216 1,587 8.4 0.10 0.09 0.12
Year 3 12,917 12,265 1,008 1,316 7.8 0.11 0.08 0.11
Year 4 11,628 11,081 839 1,048 7.2 0.10 0.08 0.10
Year 5 10,514 9,997 747 938 7.1 0.10 0.07 0.09
*N=number surviving to beginning of each time period
**PY=person years accumulated by patients during each period
†Hospitalization count in each period
‡% gives the proportion of patients hospitalized
§Frequency expressed as hospitalizations per patient hospitalized (per month)
#Hazard expressed as patients hospitalized per patient year
°Rate expressed as hospitalizations per patient yearBMC Health Services Research 2006, 6:99 http://www.biomedcentral.com/1472-6963/6/99
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gesting that the effects are relatively acute and then the
underlying age and general condition of patients takes
over.
Use of administrative databases such as those of Saskatch-
ewan Health has some limitations. Definition of the pop-
ulations and identification of events is dependant on
accuracy of the ICD-9 codes submitted to Saskatchewan
Health. For identifying cases of stroke, two of the codes
used (434, 436) have been previously validated [26-29].
With respect to identifying outcome events, validation
work has indicated a low error rate overall [11] and this is
even lower for cardiovascular events. The observed
lengths of stay associated with hospitalizations for tran-
sient ischemic attack, however, may indicate potential
errors in coding given their duration. A study from the
Canadian province of Alberta estimated that 30% of tran-
sient ischemic attacks reported in the Calgary region were
incorrectly coded [30], indicating that the majority of
admissions are coded correctly. Given the comprehensive
health insurance, and lack of other facilities, all residents
seek care within the system. Moreover, given the global
hospital budgets extant in Canada, there is no reimburse-
ment incentive to alter coding. Although the majority of
index strokes in this study were first recorded in the phy-
sician file, this does not imply that most of these patients
were not hospitalized. Rather it results from the way cases
are recorded in the databases, with the physician claims in
one set and the hospital records in another. As patients
with stroke may first be seen by a physician in the emer-
gency room or outpatient clinic, this "visit" becomes the
index recording rather than the acute hospitalization. This
should not affect in any way the interpretation of the
results of this study.
Another limitation to administrative data is that they do
not contain clinical information such as results of labora-
tory tests, smoking, family history, and blood pressure
and so on. This confines the set of predictive factors to the
information that appears on billing records or is stored in
other linked data sets. The factors identified may, thus, be
carrying part of the effect of clinical determinants and
might not be as strong predictors if these latter ones were
to be included.
Conclusion
Despite these limitations, the data we obtained from Sas-
katchewan Health provide a wide-ranging, novel assess-
ment of a large cohort of patients diagnosed with a stroke
over five years. These estimates can provide inputs to anal-
yses of the economic efficiency of new stroke therapies
and a basis for future studies of this type. It is clear from
our findings that patients who have had a stroke are
expensive to manage, with frequent, costly hospitaliza-
tions, which place a significant burden on them, their
families and the health care system.
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Costs due specific hospitalizations, accumulated each year  after stroke in 18,695 patients, by reason for admission Figure 1
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0
5,000
10,000
15,000
20,000
25,000
30,000
12345
Time Since Stroke (years)
C
o
s
t
 
(
2
0
0
2
 
C
A
D
$
)
Stroke/TIA MI/angina Other cardiovascular disease PAD Bleeds
Table 4: Subsequent hospitalizations for stroke and transient 
ischemic attack among patients suffering an index ischemic 
stroke
Hospitalizations due to
Time Period Stroke TIA
N (%*) Rate† N (%*) Rate†
Month 1 800 (32.8) 0.56 142 (5.8) 0.10
Month 2 312 (21.4) 0.23 51 (3.5) 0.04
Months 3–6 645 (14.7) 0.12 164 (3.7) 0.03
Months 7–12 433 (8.9) 0.06 152 (3.1) 0.02
Year 2 545 (6.7) 0.04 214 (2.7) 0.02
Year 3 384 (5.6) 0.03 174 (2.5) 0.01
Year 4 344 (5.8) 0.03 102 (1.7) 0.01
Year 5 257 (4.8) 0.03 112 (2.1) 0.01
*Percent of all cause hospitalization
†Rate expressed as hospitalizations per patient yearBMC Health Services Research 2006, 6:99 http://www.biomedcentral.com/1472-6963/6/99
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